Bevacizumab in Advanced Angiosarcoma: What Is the Reality?

Affiliations

Comment

Bivas Biswas et al. J Clin Oncol. 2016.

. 2016 Mar 1;34(7):764.

doi: 10.1200/JCO.2015.64.2181. Epub 2015 Dec 28.

No abstract available

Comment in

Reply to B. Biswas and D. Dabkara.
Penel N, Ray-Coquard I. Penel N, et al. J Clin Oncol. 2016 Mar 1;34(7):764-5. doi: 10.1200/JCO.2015.65.4426. Epub 2015 Dec 28. J Clin Oncol. 2016. PMID: 26712229 No abstract available.

Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial.
Ray-Coquard IL, Domont J, Tresch-Bruneel E, Bompas E, Cassier PA, Mir O, Piperno-Neumann S, Italiano A, Chevreau C, Cupissol D, Bertucci F, Bay JO, Collard O, Saada-Bouzid E, Isambert N, Delcambre C, Clisant S, Le Cesne A, Blay JY, Penel N. Ray-Coquard IL, et al. J Clin Oncol. 2015 Sep 1;33(25):2797-802. doi: 10.1200/JCO.2015.60.8505. Epub 2015 Jul 27. J Clin Oncol. 2015. PMID: 26215950 Clinical Trial.